SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-192102
Filing Date
2014-05-09
Accepted
2014-05-09 14:26:54
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d715544d10q.htm 10-Q 409339
2 EX-31.1 d715544dex311.htm EX-31.1 8727
3 EX-31.2 d715544dex312.htm EX-31.2 8660
4 EX-32.1 d715544dex321.htm EX-32.1 3353
5 EX-32.2 d715544dex322.htm EX-32.2 3395
  Complete submission text file 0001193125-14-192102.txt   3477362

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcrx-20140331.xml EX-101.INS 425110
7 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20140331.xsd EX-101.SCH 44810
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20140331_cal.xml EX-101.CAL 42721
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20140331_def.xml EX-101.DEF 102280
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20140331_lab.xml EX-101.LAB 333966
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20140331_pre.xml EX-101.PRE 199485
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 14828403
SIC: 2836 Biological Products, (No Diagnostic Substances)